🇺🇸 FDA
Patent

US 12054487

Muscarinic acetylcholine M1 receptor antagonists

granted A61KA61K31/136A61K31/137

Quick answer

US patent 12054487 (Muscarinic acetylcholine M1 receptor antagonists) held by Contineum Therapeutics, Inc. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Contineum Therapeutics, Inc.
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/136, A61K31/137, A61K31/198, A61K31/277